Click to go to DrugInjuryLaw Home

Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation

Free Case Evaluation

Byetta Information  (Visit Our New Site >>)

What is Byetta?


Byetta (exenatide) is an injectable type 2 diabetes drug marketed by Amylin Pharmaceuticals, Inc. and Eli Lilly & Company. This diabetes medication was approved by the FDA in 2005 as an adjunct to diet and exercise to improve glycemic control. Byetta is not used for treatment of patients with type 1 diabetes.

Our law firm represents people in personal injury and wrongful death cases that involve serious side effects and adverse reactions which may have been caused by the use of Byetta (exenatide) such as the following:

  • Pancreatic Cancer, or Pancreas Cancer
  • Thyroid Cancer

Other diabetes medications such as Januvia and/or Victoza can cause these cancers, also -- even in there is no Byetta involved.

NOTE: We are no longer taking cases involving:

  • Pancreatitis: Acute / Hemorrhagic / Necrotizing
  • Kidney Failure
  • Renal Insufficiency

October 2009 FDA Letter About Byetta Demands That Several Safety Studies Be Done By Drug Company

This letter from the FDA warns that there are several serious side effects that the FDA has concerns about.  Among these side effects are potentially life threatening conditions and diseases such as pancreatitis, pancreatic cancer, thyroid Neoplasm, and acute renal failure.

FDA Alert About Diabetes Medication Byetta Being Linked To Acute Pancreatitis Issued In October 2007

The FDA issued a MedWatch alert back in October 2007 reporting that it had received 30 reports of acute pancreatitis in patients taking Byetta (exenatide) since this diabetes medication was first approved by the agency in April 2005. Further, as part of this FDA warning, the Byetta package insert, or label, was changed to include information about pancreatitis in the "Precautions" section.

Diabetes Medication Byetta Has Been Related To Hemorrhagic Pancreatitis And Necrotizing Pancreatitis

Since October 2007 the FDA has received reports of six cases of hemorrhagic pancreatitis or necrotizing pancreatitis associated with the use of Byetta (exenatide).  In August 2008 the FDA issued a MedWatch email alert regarding this startling information.

Byetta Gets New Warning About Severe Kidney Side Effects, Including Acute Renal Failure

In early November 2009 the FDA announced its approval of the revised Byetta package insert which will now include safety information about the numerous case reports of kidney-related side effects, including kidney failure and renal insufficiency.

Byetta Class Actions

We believe that people who suffered a serious injury which may have been caused by the use of Byetta are better served when an individual lawsuit is filed on their behalf. A serious injury case should not be filed as part of any Byetta class action together with the claims of many other people who may have had different injuries possibly caused by this type 2 diabetes drug.

Legal Compensation for Byetta Injuries

If you experienced serious side effects or adverse reaction which may have been caused by the use of Byetta, you may have a claim for legal compensation. Legal compensation claims involving injuries which may have been caused by the use of Byetta are made by filing a lawsuit in court. All states have statutes of limitations that determine the time period allowed to file a Byetta lawsuit.

Free Byetta Case Evaluation

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential.  You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

NOTE:  This Case Evaluation form can also be completed for situations that involve other diabetes medications such as Januvia and/or Victoza -- even in there is no Byetta involved.  

Drug Injury Watch: Byetta News and Commentary

Byetta / Januvia / Victoza: Update On Possible Association Between These Newer Diabetes Drugs And Pancreatic Cancer As A Side Effect

Drug Safety Regulatory Developments And The Ongoing Academic Discussions About Provocative 2013 Medical Journal Article By Peter Butler At UCLA

SUMMARY: In August we learned that both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) believe that the currently available data does not confirm recent concerns over an increased risk for pancreatic cancer with glucagonlike peptide-1 (GLP-1)-based diabetes therapies Byetta (exenatide), Januvia (sitagliptin), and Victoza (liraglutide).

And then there was the continuing debate about that controversial 2013 article by UCLA medical researcher Peter Butler, "Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors".

[Read this article in full at original source]


Earlier Byetta articles by Tom Lamb on the Drug Injury Watch blog:

Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?

Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, And Victoza -- Little Is Known About Long-Term Effects

Byetta And Januvia: More Debate About The Possible Increased Risk Of Pancreatitis, Pancreatic Cancer, And Thyroid Cancer

Acute Pancreatitis Case Associated With Victoza Use, Similar To Byetta And Januvia Case Reports

Gastroenterology Medical Journal Withdraws Januvia / Byetta Article Due To Letters From Drug Companies

New Extensively Documented Case Report About Patient With Probable Byetta-Induced Pancreatitis  

FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure  

Diabetes Drug Byetta Linked To Altered Kidney Function And Cases Of Renal Failure

A Review Of Recent Research On Issue Of Whether Januvia Can Cause Pancreatitis

Case Report Of Woman With Likely Byetta-Induced Acute Pancreatitis

Warnings About Byetta Associated With Risk Of Severe Pancreatitis And Renal Failure

August 2008: Byetta Associated With Hemorrhagic Pancreatitis And Necrotizing Pancreatitis

More Information About Reports Of Byetta Use Being Linked To Acute Pancreatitis

December 2007 FDA "Patient Safety News" Videos For Doctors Online

FDA Alerts Doctors About Diabetes Drug Byetta And Acute Pancreatitis Reports

All content by attorney Tom Lamb

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535